Product Information
DEXTROAMPHETAMINE ER 5 MG CAP is a generic product labeled by Actavis Pharma, Inc., priced at $0.9617 per EA under NDC 45963030309. Its NADAC has been published 627 times since Aug 20, 2014.
FDA first approved this application on Nov 30, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
45963030309
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA203901FDA Approved
11/30/2012
TE Code
AB
On Market Since
6/19/2014
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMPHETAMINE ER 5 MG CAP has been published 627 times since Aug 20, 2014, and over the history we have for it it has declined 64.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9617 per EA |
|---|---|
| All-time high | $2.9203 (May 13, 2015) |
| All-time low | $0.6951 (Jun 19, 2024) |
| 52-week high | $1.3521 |
| 52-week low | $0.8900 |
| Median price | $1.2713 |
| Average price | $1.5033 |
| Largest weekly change | +62.1% (Jun 21, 2023) |
| Weeks tracked | 627 |
| Tracking since | Aug 20, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dextroamphetamine sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMPHETAMINE ER 5 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMPHETAMINE ER 5 MG CAP, manufactured by Actavis Pharma, Inc., is $0.9617 per EA (NDC 45963030309), effective Aug 19, 2026.
How has the price of DEXTROAMPHETAMINE ER 5 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMPHETAMINE ER 5 MG CAP has declined 64.2%. It has been tracked across 627 weekly CMS publications since Aug 20, 2014.
What are the highest and lowest recorded NADAC prices for DEXTROAMPHETAMINE ER 5 MG CAP?
Since Aug 20, 2014, the NADAC for DEXTROAMPHETAMINE ER 5 MG CAP has ranged from a low of $0.6951 (Jun 19, 2024) to a high of $2.9203 (May 13, 2015), with a median of $1.2713 per EA.
Are there cheaper alternatives to DEXTROAMPHETAMINE ER 5 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMPHETAMINE ER 5 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMPHETAMINE ER 5 MG CAP?
DEXTROAMPHETAMINE ER 5 MG CAP (NDC 45963030309) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.